FSPKF (Fisher & Paykel Healthcare) Other Current Assets: $20 Mil (As of Mar. 2026)


FSPKF Fisher & Paykel Healthcare Corp Ltd FSPKF
90 GF Score
Price $22.52
GF Value $25.21
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is Fisher & Paykel Healthcare Other Current Assets?

Fisher & Paykel Healthcare FSPKF +9.59% 90 Other Current Assets is $20 Mil as of Mar. 2026. GuruFocus rates FSPKF with a GF Score™ of 90/100 and a GF Value™ of $25.21 (Modestly Undervalued). The stock has 2 warning signs investors should review.

Fisher & Paykel Healthcare's other current assets for the quarter that ended in Mar. 2026 was $20 Mil.

Fisher & Paykel Healthcare's quarterly other current assets increased from Mar. 2025 ($13 Mil) to Sep. 2025 ($22 Mil) but then declined from Sep. 2025 ($22 Mil) to Mar. 2026 ($20Mil).

Fisher & Paykel Healthcare's annual other current assets declined from Mar. 2024 ($28 Mil) to Mar. 2025 ($13 Mil) increased from Mar. 2025 ($13 Mil) to Mar. 2026 ($20 Mil).


Fisher & Paykel Healthcare Other Current Assets Related Terms


Fisher & Paykel Healthcare Other Current Assets Historical Data

* Premium members only.

The historical data trend for Fisher & Paykel Healthcare's Other Current Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Fisher & Paykel Healthcare Other Current Assets Chart

Fisher & Paykel Healthcare Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Other Current Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 44.44 42.77 27.55 13.40 20.12

Fisher & Paykel Healthcare Semi-Annual Data
Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Other Current Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 27.55 40.45 13.40 21.82 20.12
FSPKF
90GF Score
Fisher & Paykel Healthcare Corp Ltd FSPKF
Other Current Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Fisher & Paykel Healthcare Other Current Assets Calculation

Technically, the other current assets line may include any asset that will be used up within the next 12 months. However, other current assets never include assets that are listed elsewhere in the current assets section of the balance sheet. For this reason, other current assets are almost never:


Cash
Trade Receivables
Inventory

The assets grouped under other current assets are most commonly:


Prepaid Expenses
Tax Assets
Non-Trade Receivables
Other (too numerous to list)

Some companies can and do choose to report each of these items separately.

Other current assets may be made up largely of Prepaid Expenses - unless these are listed on a separate line of the balance sheet.

Prepaid expenses are exactly what they sound like. If a company pays a $30 million insurance premium on the last day of June that will provide coverage for the entire month of July, the company will record a $30 million prepaid expense to account for the insurance expense it will show in July that it already paid for in June.

Tax assets can be quite complex. It is not common for companies to have both tax assets and tax liabilities. It is important that investors take note of both items when considering future taxes.

Non-Trade receivables are rarely a large item. They include money owed to the company by non-customers. Non-trade receivables can be caused by related party transactions, the sale of a business unit, etc. The notes to the company's financial statements will often provide much more detail on this item if it is truly important.

There are a variety of other current assets like non-trade receivables which are simply too numerous to list. If a company is following correct reporting procedures, it should not lump items that are different from one another and yet individually important to the company together under the line Other Current Assets.

At most companies, other current assets are a small and unimportant part of the total balance sheet.

Frequently Asked Questions Learn more about Other Current Assets →
What does a Other Current Assets of $20 Mil mean?
Fisher & Paykel Healthcare (FSPKF) has a Other Current Assets of $20 Mil as of Mar. 2026. Other current assets as record on a company's balance sheet not categorized as standard assets. View historical data on Fisher & Paykel Healthcare.
Is Fisher & Paykel Healthcare's Other Current Assets too high?
Fisher & Paykel Healthcare's current Other Current Assets is $20 Mil. Overall, Fisher & Paykel Healthcare has a GF Score™ of 90/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Fisher & Paykel Healthcare's Other Current Assets compare to ISRG and BDX?
Fisher & Paykel Healthcare's Other Current Assets of $20 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Assets for a Medical Devices & Instruments company?
A good Other Current Assets depends on the Medical Devices & Instruments industry context. However, Other Current Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Assets mean?
A high Other Current Assets can signal that a stock is expensive relative to its fundamentals. Other current assets as record on a company's balance sheet not categorized as standard assets. View historical data on Fisher & Paykel Healthcare. Fisher & Paykel Healthcare's current Other Current Assets is $20 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fisher & Paykel Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Fisher & Paykel Healthcare (FSPKF) is currently considered Modestly Undervalued. The stock's GF Value™ is $25.21, compared to a current price of $22.52 — trading 10.7% below its estimated fair value. The current Other Current Assets is $20 Mil. Fisher & Paykel Healthcare's overall GF Score™ is 90/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Assets calculated?
Other Current Assets is calculated from a company's financial statements. For Fisher & Paykel Healthcare (FSPKF), the current Other Current Assets is $20 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Fisher & Paykel Healthcare (FSPKF) Overvalued in 2026?

Based on GuruFocus' analysis, Fisher & Paykel Healthcare stock appears to be undervalued. The current stock price of $22.52 is trading 10.7% below its estimated GF Value™ of $25.21. GuruFocus considers Fisher & Paykel Healthcare to be Modestly Undervalued.

Key valuation signals for FSPKF:

  • Other Current Assets: $20 Mil
  • GF Value™: $25.21 vs. price of $22.52 (10.7% below fair value)
  • GF Score™: 90/100 with 2 warning signs

No single metric tells the full story. See the FSPKF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Fisher & Paykel Healthcare Business Description

Address 15 Maurice Paykel Place, East Tamaki, Auckland, NTL, NZL, 2013
Fisher & Paykel Healthcare is one of the three largest respiratory care device companies globally. It is the market leader in hospital use of humidifiers, masks, and related consumables, and the number three player in the at-home treatment of sleep apnea using respiratory devices. Both the hospital and homecare markets for respiratory devices are growing strongly in the developed markets in which Fisher & Paykel has a presence. The company earns roughly half of its revenue in North America, around a quarter in Europe, and approximately a fifth in Asia-Pacific. Fisher conducts its own R&D and has thousands of patents and pending applications. It manufactures in New Zealand, Mexico, and China, and has a multichannel distribution model.
90GF Score

Get the complete analysis for FSPKF

Other Current Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$22.52
Price
$25.21
GF Value